Proteostasis Therapeutics Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,594.00
8,793.00
13,844.00
85,510.00
74,756.00
118,379
Total Accounts Receivable
2,733.00
1,424.00
918.00
668.00
-
-
Other Current Assets
454.00
370.00
180.00
4,059.00
1,377.00
2,481
Total Current Assets
5,781.00
10,587.00
14,942.00
90,237.00
76,133.00
120,860
Net Property, Plant & Equipment
867.00
575.00
566.00
541.00
16,567.00
605
Total Investments and Advances
294.00
294.00
294.00
294.00
1,656.00
828
Other Assets
273.00
326.00
2,888.00
68.00
33.00
13,849
Total Assets
7,215.00
11,782.00
18,690.00
91,140.00
94,389.00
136,142
Accounts Payable
700.00
1,889.00
3,330.00
2,021.00
2,098.00
Other Current Liabilities
2,229.00
4,144.00
6,506.00
6,733.00
8,217.00
Total Current Liabilities
2,929.00
6,033.00
9,836.00
8,754.00
10,315.00
Long-Term Debt
-
10,000.00
-
-
-
Other Liabilities
2,122.00
3,974.00
4,664.00
930.00
15,340.00
Total Liabilities
5,051.00
20,007.00
14,500.00
9,684.00
25,655.00
Common Equity (Total)
73,726.00
95,084.00
108,102.00
81,456.00
68,734.00
Total Shareholders' Equity
2,164.00
8,225.00
4,190.00
81,456.00
68,734.00
Total Equity
2,164.00
8,225.00
4,190.00
81,456.00
68,734.00
Liabilities & Shareholders' Equity
7,215.00
11,782.00
18,690.00
91,140.00
94,389.00
Preferred Stock (Carrying Value)
75,890.00
86,859.00
112,292.00
-
-
About Proteostasis Therapeutics
View Profile
